InVivo Therapeutics Company
.jpg)
InVivo Therapeutics is a medical device company focused on developing restoration treatments for patients with spinal cord-injuries.
Funding Status:
IPO
Industry:
General Healthcare
Total Funding:
$97 400 000
Estimated Revenue:
$1M to $10M
Last Funding Type:
Post-IPO Equity
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
2005-01-01
Last Funding Date:
2020-03-11